Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hypertriglyceridemia
|
16 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.820 | 0.750 | 1 | 2010 | 2016 | ||||
Triglycerides measurement
|
837 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 19 | 2008 | 2019 | ||||
Serum total cholesterol measurement
|
766 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 8 | 2010 | 2019 | ||||
Glomerular Filtration Rate
|
1031 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 5 | 2013 | 2019 | ||||
Uric acid measurement (procedure)
|
550 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 5 | 2009 | 2019 | ||||
C-reactive protein measurement
|
250 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 4 | 2011 | 2019 | ||||
Fasting blood glucose measurement
|
114 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 4 | 2012 | 2019 | ||||
Serum albumin measurement
|
28 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 4 | 2010 | 2018 | ||||
Arthritis, Gouty
|
92 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 3 | 2010 | 2019 | ||||
Gout
|
92 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 3 | 2010 | 2019 | ||||
Platelet Count measurement
|
456 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 3 | 2011 | 2018 | ||||
Serum gamma-glutamyl transferase measurement
|
105 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 2 | 2011 | 2018 | ||||
elevated blood glucose level
|
69 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 1 | 2009 | 2018 | ||||
Glucose measurement
|
69 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 1 | 2009 | 2018 | ||||
Glucose tolerance test
|
28 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 1 | 2010 | 2010 | ||||
Protein C antigen measurement
|
19 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 1 | 2010 | 2017 | ||||
Protein C measurement
|
19 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.800 | 1.000 | 1 | 2010 | 2017 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
844 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.770 | 1.000 | 2 | 2008 | 2019 | ||||
Non-alcoholic Fatty Liver Disease
|
37 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.760 | 1.000 | 1 | 2014 | 2019 | ||||
White Blood Cell Count procedure
|
1003 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.700 | 1.000 | 4 | 2016 | 2019 | ||||
Low density lipoprotein cholesterol measurement
|
731 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.700 | 1.000 | 3 | 2018 | 2019 | ||||
Amino acids measurement
|
92 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.700 | 1.000 | 2 | 2016 | 2016 | ||||
Biliary calculi
|
31 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.700 | 1.000 | 2 | 2016 | 2018 | ||||
Body Height
|
3972 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.700 | 1.000 | 2 | 2019 | 2019 | ||||
Creatinine measurement, serum (procedure)
|
243 | 0.645 | 0.600 | 2 | 27508073 | missense variant | T/C;G | snv | 0.63; 4.0E-06 | 0.68 | 0.700 | 1.000 | 2 | 2010 | 2016 |